SoftBank-Backed Alto Pharmacy to be Acquired by Paulus Holdings for $1-1.5 Billion

Alto Pharmacy, a digital pharmaceutical startup backed by SoftBank, has agreed to be acquired by Paulus Holdings for $1 billion to $1.5 billion. The acquisition marks a decline in Alto's valuation from $1.8 billion during the pandemic boom to $786 million. Paulus Holdings has previously acquired digital pharmacy company Truepill through its affiliate, LetsGetChecked.